Search
Acifluorfen
go.drugbank.com/drugs/DB07338ExperimentalAcifluorfen is a protoporphyrinogen oxidase inhibitor.
Categories: Compounds used in a research, industrial, or household setting4-Nitrophenyl Phosphate
go.drugbank.com/drugs/DB04214ExperimentalCategories: Compounds used in a research, industrial, or household settingDenopamine
go.drugbank.com/drugs/DB21277ExperimentalDenopamine is a small molecule drug. Denopamine has a monoisotopic molecular weight of 317.16 Da.
Categories: Compounds used in a research, industrial, or household settingEgtazic acid
go.drugbank.com/drugs/DB19986ExperimentalEgtazic acid is a small molecule drug. Egtazic acid has a monoisotopic molecular weight of 380.14 Da.
Categories: Compounds used in a research, industrial, or household settingNirogacestat
go.drugbank.com/drugs/DB12005ApprovedInvestigationalDesmoid tumors are typically characterized by aberrant activation in Notch signaling. … It was previously granted breakthrough therapy, fast track, and orphan drug designations for the treatment of desmoid tumors, and the final approval was based on positive results obtained in the Phase
Prezatide copper
go.drugbank.com/drugs/DB14683InvestigationalPrezatide is used in cosmetic products for the skin and hair. … It is known to aid wound healing and its potential applications in chronic obstructive pulmonary disease and metastatic colon cancer are currently being investigated.
XL228
go.drugbank.com/drugs/DB05184InvestigationalXL228 is a novel anticancer compound designed to inhibit the insulin-like growth factor type-1 receptor (IGF1R), Src and Abl tyrosine kinases – targets that play crucial roles in cancer cell proliferation
Biomed 101
go.drugbank.com/drugs/DB05851InvestigationalBiomed 101 is investigated for use/treatment in adverse effects (chemotherapy) and renal cell carcinoma. Biomed 101 is a solid.
XL844
go.drugbank.com/drugs/DB05149InvestigationalXL844 is a potent inhibitor of the checkpoint kinases CHK1 and CHK2, which induce cell cycle arrest in response to a variety of DNA damaging agents.
Terevalefim
go.drugbank.com/drugs/DB16397InvestigationalTerevalefim is under investigation in clinical trial NCT02474667 (Reduce the Severity of DGF in Recipients of a Deceased Donor Kidney).